Question

The M72/AS01E vaccine candidate launched in 2024 almost after a century of BCG vaccine discovery is effective against which of the following diseases?

• A. Malaria
• B. COVID-19
• C. HIV
• D. Tuberculosis

Answer 1

Answer:

D. Tuberculosis

The M72/AS01E vaccine candidate, launched in 2024, is designed to prevent tuberculosis (TB) disease, specifically active pulmonary TB, in adults with latent Mycobacterium tuberculosis (Mtb) infection. M72/AS01E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine